Request for Covid-19 Impact Assessment of this Report
The United States IVIG market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global IVIG market, reaching US$ million by the year 2028. As for the Europe IVIG landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main IVIG players cover Green Cross, BSV, Hualan Bio, and RAAS, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of IVIG market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Injection IVIG
Lyophilized Powder IVIG
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global IVIG Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for IVIG by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for IVIG by Country/Region, 2017, 2022 & 2028
2.2 IVIG Segment by Type
2.2.1 Injection IVIG
2.2.2 Lyophilized Powder IVIG
2.3 IVIG Sales by Type
2.3.1 Global IVIG Sales Market Share by Type (2017-2022)
2.3.2 Global IVIG Revenue and Market Share by Type (2017-2022)
2.3.3 Global IVIG Sale Price by Type (2017-2022)
2.4 IVIG Segment by Application
2.4.1 Multiple Sclerosis(MS)
2.4.2 Myasthenia Gravis(MG)
2.4.3 Multifocal Motor Neuropathy(MMN)
2.4.4 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
2.4.5 Dermatomyositis
2.4.6 Polymyositis
2.5 IVIG Sales by Application
2.5.1 Global IVIG Sale Market Share by Application (2017-2022)
2.5.2 Global IVIG Revenue and Market Share by Application (2017-2022)
2.5.3 Global IVIG Sale Price by Application (2017-2022)
3 Global IVIG by Company
3.1 Global IVIG Breakdown Data by Company
3.1.1 Global IVIG Annual Sales by Company (2020-2022)
3.1.2 Global IVIG Sales Market Share by Company (2020-2022)
3.2 Global IVIG Annual Revenue by Company (2020-2022)
3.2.1 Global IVIG Revenue by Company (2020-2022)
3.2.2 Global IVIG Revenue Market Share by Company (2020-2022)
3.3 Global IVIG Sale Price by Company
3.4 Key Manufacturers IVIG Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers IVIG Product Location Distribution
3.4.2 Players IVIG Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for IVIG by Geographic Region
4.1 World Historic IVIG Market Size by Geographic Region (2017-2022)
4.1.1 Global IVIG Annual Sales by Geographic Region (2017-2022)
4.1.2 Global IVIG Annual Revenue by Geographic Region
4.2 World Historic IVIG Market Size by Country/Region (2017-2022)
4.2.1 Global IVIG Annual Sales by Country/Region (2017-2022)
4.2.2 Global IVIG Annual Revenue by Country/Region
4.3 Americas IVIG Sales Growth
4.4 APAC IVIG Sales Growth
4.5 Europe IVIG Sales Growth
4.6 Middle East & Africa IVIG Sales Growth
5 Americas
5.1 Americas IVIG Sales by Country
5.1.1 Americas IVIG Sales by Country (2017-2022)
5.1.2 Americas IVIG Revenue by Country (2017-2022)
5.2 Americas IVIG Sales by Type
5.3 Americas IVIG Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC IVIG Sales by Region
6.1.1 APAC IVIG Sales by Region (2017-2022)
6.1.2 APAC IVIG Revenue by Region (2017-2022)
6.2 APAC IVIG Sales by Type
6.3 APAC IVIG Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe IVIG by Country
7.1.1 Europe IVIG Sales by Country (2017-2022)
7.1.2 Europe IVIG Revenue by Country (2017-2022)
7.2 Europe IVIG Sales by Type
7.3 Europe IVIG Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa IVIG by Country
8.1.1 Middle East & Africa IVIG Sales by Country (2017-2022)
8.1.2 Middle East & Africa IVIG Revenue by Country (2017-2022)
8.2 Middle East & Africa IVIG Sales by Type
8.3 Middle East & Africa IVIG Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of IVIG
10.3 Manufacturing Process Analysis of IVIG
10.4 Industry Chain Structure of IVIG
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 IVIG Distributors
11.3 IVIG Customer
12 World Forecast Review for IVIG by Geographic Region
12.1 Global IVIG Market Size Forecast by Region
12.1.1 Global IVIG Forecast by Region (2023-2028)
12.1.2 Global IVIG Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global IVIG Forecast by Type
12.7 Global IVIG Forecast by Application
13 Key Players Analysis
13.1 Green Cross
13.1.1 Green Cross Company Information
13.1.2 Green Cross IVIG Product Offered
13.1.3 Green Cross IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Green Cross Main Business Overview
13.1.5 Green Cross Latest Developments
13.2 BSV
13.2.1 BSV Company Information
13.2.2 BSV IVIG Product Offered
13.2.3 BSV IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 BSV Main Business Overview
13.2.5 BSV Latest Developments
13.3 Hualan Bio
13.3.1 Hualan Bio Company Information
13.3.2 Hualan Bio IVIG Product Offered
13.3.3 Hualan Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Hualan Bio Main Business Overview
13.3.5 Hualan Bio Latest Developments
13.4 RAAS
13.4.1 RAAS Company Information
13.4.2 RAAS IVIG Product Offered
13.4.3 RAAS IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 RAAS Main Business Overview
13.4.5 RAAS Latest Developments
13.5 YUAN DA SHUYANG
13.5.1 YUAN DA SHUYANG Company Information
13.5.2 YUAN DA SHUYANG IVIG Product Offered
13.5.3 YUAN DA SHUYANG IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 YUAN DA SHUYANG Main Business Overview
13.5.5 YUAN DA SHUYANG Latest Developments
13.6 Kangbao Bio
13.6.1 Kangbao Bio Company Information
13.6.2 Kangbao Bio IVIG Product Offered
13.6.3 Kangbao Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Kangbao Bio Main Business Overview
13.6.5 Kangbao Bio Latest Developments
13.7 Tiantan Bio
13.7.1 Tiantan Bio Company Information
13.7.2 Tiantan Bio IVIG Product Offered
13.7.3 Tiantan Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Tiantan Bio Main Business Overview
13.7.5 Tiantan Bio Latest Developments
13.8 Taibang Bio
13.8.1 Taibang Bio Company Information
13.8.2 Taibang Bio IVIG Product Offered
13.8.3 Taibang Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Taibang Bio Main Business Overview
13.8.5 Taibang Bio Latest Developments
13.9 Weiguang Bio
13.9.1 Weiguang Bio Company Information
13.9.2 Weiguang Bio IVIG Product Offered
13.9.3 Weiguang Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Weiguang Bio Main Business Overview
13.9.5 Weiguang Bio Latest Developments
13.10 SIBP
13.10.1 SIBP Company Information
13.10.2 SIBP IVIG Product Offered
13.10.3 SIBP IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 SIBP Main Business Overview
13.10.5 SIBP Latest Developments
13.11 TONROL
13.11.1 TONROL Company Information
13.11.2 TONROL IVIG Product Offered
13.11.3 TONROL IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 TONROL Main Business Overview
13.11.5 TONROL Latest Developments
13.12 RUIDE Bio
13.12.1 RUIDE Bio Company Information
13.12.2 RUIDE Bio IVIG Product Offered
13.12.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 RUIDE Bio Main Business Overview
13.12.5 RUIDE Bio Latest Developments
13.13 BOYA Bio
13.13.1 BOYA Bio Company Information
13.13.2 BOYA Bio IVIG Product Offered
13.13.3 BOYA Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 BOYA Bio Main Business Overview
13.13.5 BOYA Bio Latest Developments
13.14 RUIDE Bio
13.14.1 RUIDE Bio Company Information
13.14.2 RUIDE Bio IVIG Product Offered
13.14.3 RUIDE Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 RUIDE Bio Main Business Overview
13.14.5 RUIDE Bio Latest Developments
13.15 Xinxing Medicine
13.15.1 Xinxing Medicine Company Information
13.15.2 Xinxing Medicine IVIG Product Offered
13.15.3 Xinxing Medicine IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Xinxing Medicine Main Business Overview
13.15.5 Xinxing Medicine Latest Developments
13.16 Weilun Bio
13.16.1 Weilun Bio Company Information
13.16.2 Weilun Bio IVIG Product Offered
13.16.3 Weilun Bio IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Weilun Bio Main Business Overview
13.16.5 Weilun Bio Latest Developments
13.17 WIBP
13.17.1 WIBP Company Information
13.17.2 WIBP IVIG Product Offered
13.17.3 WIBP IVIG Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 WIBP Main Business Overview
13.17.5 WIBP Latest Developments
14 Research Findings and Conclusion
Table 1. IVIG Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. IVIG Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Injection IVIG
Table 4. Major Players of Lyophilized Powder IVIG
Table 5. Global IVIG Sales by Type (2017-2022) & (K Pcs)
Table 6. Global IVIG Sales Market Share by Type (2017-2022)
Table 7. Global IVIG Revenue by Type (2017-2022) & ($ million)
Table 8. Global IVIG Revenue Market Share by Type (2017-2022)
Table 9. Global IVIG Sale Price by Type (2017-2022) & (USD/Pcs)
Table 10. Global IVIG Sales by Application (2017-2022) & (K Pcs)
Table 11. Global IVIG Sales Market Share by Application (2017-2022)
Table 12. Global IVIG Revenue by Application (2017-2022)
Table 13. Global IVIG Revenue Market Share by Application (2017-2022)
Table 14. Global IVIG Sale Price by Application (2017-2022) & (USD/Pcs)
Table 15. Global IVIG Sales by Company (2020-2022) & (K Pcs)
Table 16. Global IVIG Sales Market Share by Company (2020-2022)
Table 17. Global IVIG Revenue by Company (2020-2022) ($ Millions)
Table 18. Global IVIG Revenue Market Share by Company (2020-2022)
Table 19. Global IVIG Sale Price by Company (2020-2022) & (USD/Pcs)
Table 20. Key Manufacturers IVIG Producing Area Distribution and Sales Area
Table 21. Players IVIG Products Offered
Table 22. IVIG Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global IVIG Sales by Geographic Region (2017-2022) & (K Pcs)
Table 26. Global IVIG Sales Market Share Geographic Region (2017-2022)
Table 27. Global IVIG Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global IVIG Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global IVIG Sales by Country/Region (2017-2022) & (K Pcs)
Table 30. Global IVIG Sales Market Share by Country/Region (2017-2022)
Table 31. Global IVIG Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global IVIG Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas IVIG Sales by Country (2017-2022) & (K Pcs)
Table 34. Americas IVIG Sales Market Share by Country (2017-2022)
Table 35. Americas IVIG Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas IVIG Revenue Market Share by Country (2017-2022)
Table 37. Americas IVIG Sales by Type (2017-2022) & (K Pcs)
Table 38. Americas IVIG Sales Market Share by Type (2017-2022)
Table 39. Americas IVIG Sales by Application (2017-2022) & (K Pcs)
Table 40. Americas IVIG Sales Market Share by Application (2017-2022)
Table 41. APAC IVIG Sales by Region (2017-2022) & (K Pcs)
Table 42. APAC IVIG Sales Market Share by Region (2017-2022)
Table 43. APAC IVIG Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC IVIG Revenue Market Share by Region (2017-2022)
Table 45. APAC IVIG Sales by Type (2017-2022) & (K Pcs)
Table 46. APAC IVIG Sales Market Share by Type (2017-2022)
Table 47. APAC IVIG Sales by Application (2017-2022) & (K Pcs)
Table 48. APAC IVIG Sales Market Share by Application (2017-2022)
Table 49. Europe IVIG Sales by Country (2017-2022) & (K Pcs)
Table 50. Europe IVIG Sales Market Share by Country (2017-2022)
Table 51. Europe IVIG Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe IVIG Revenue Market Share by Country (2017-2022)
Table 53. Europe IVIG Sales by Type (2017-2022) & (K Pcs)
Table 54. Europe IVIG Sales Market Share by Type (2017-2022)
Table 55. Europe IVIG Sales by Application (2017-2022) & (K Pcs)
Table 56. Europe IVIG Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa IVIG Sales by Country (2017-2022) & (K Pcs)
Table 58. Middle East & Africa IVIG Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa IVIG Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa IVIG Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa IVIG Sales by Type (2017-2022) & (K Pcs)
Table 62. Middle East & Africa IVIG Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa IVIG Sales by Application (2017-2022) & (K Pcs)
Table 64. Middle East & Africa IVIG Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of IVIG
Table 66. Key Market Challenges & Risks of IVIG
Table 67. Key Industry Trends of IVIG
Table 68. IVIG Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. IVIG Distributors List
Table 71. IVIG Customer List
Table 72. Global IVIG Sales Forecast by Region (2023-2028) & (K Pcs)
Table 73. Global IVIG Sales Market Forecast by Region
Table 74. Global IVIG Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global IVIG Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas IVIG Sales Forecast by Country (2023-2028) & (K Pcs)
Table 77. Americas IVIG Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC IVIG Sales Forecast by Region (2023-2028) & (K Pcs)
Table 79. APAC IVIG Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe IVIG Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Europe IVIG Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa IVIG Sales Forecast by Country (2023-2028) & (K Pcs)
Table 83. Middle East & Africa IVIG Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global IVIG Sales Forecast by Type (2023-2028) & (K Pcs)
Table 85. Global IVIG Sales Market Share Forecast by Type (2023-2028)
Table 86. Global IVIG Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global IVIG Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global IVIG Sales Forecast by Application (2023-2028) & (K Pcs)
Table 89. Global IVIG Sales Market Share Forecast by Application (2023-2028)
Table 90. Global IVIG Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global IVIG Revenue Market Share Forecast by Application (2023-2028)
Table 92. Green Cross Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 93. Green Cross IVIG Product Offered
Table 94. Green Cross IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 95. Green Cross Main Business
Table 96. Green Cross Latest Developments
Table 97. BSV Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 98. BSV IVIG Product Offered
Table 99. BSV IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 100. BSV Main Business
Table 101. BSV Latest Developments
Table 102. Hualan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 103. Hualan Bio IVIG Product Offered
Table 104. Hualan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 105. Hualan Bio Main Business
Table 106. Hualan Bio Latest Developments
Table 107. RAAS Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 108. RAAS IVIG Product Offered
Table 109. RAAS IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 110. RAAS Main Business
Table 111. RAAS Latest Developments
Table 112. YUAN DA SHUYANG Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 113. YUAN DA SHUYANG IVIG Product Offered
Table 114. YUAN DA SHUYANG IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 115. YUAN DA SHUYANG Main Business
Table 116. YUAN DA SHUYANG Latest Developments
Table 117. Kangbao Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 118. Kangbao Bio IVIG Product Offered
Table 119. Kangbao Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 120. Kangbao Bio Main Business
Table 121. Kangbao Bio Latest Developments
Table 122. Tiantan Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 123. Tiantan Bio IVIG Product Offered
Table 124. Tiantan Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 125. Tiantan Bio Main Business
Table 126. Tiantan Bio Latest Developments
Table 127. Taibang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 128. Taibang Bio IVIG Product Offered
Table 129. Taibang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 130. Taibang Bio Main Business
Table 131. Taibang Bio Latest Developments
Table 132. Weiguang Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 133. Weiguang Bio IVIG Product Offered
Table 134. Weiguang Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 135. Weiguang Bio Main Business
Table 136. Weiguang Bio Latest Developments
Table 137. SIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 138. SIBP IVIG Product Offered
Table 139. SIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 140. SIBP Main Business
Table 141. SIBP Latest Developments
Table 142. TONROL Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 143. TONROL IVIG Product Offered
Table 144. TONROL IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 145. TONROL Main Business
Table 146. TONROL Latest Developments
Table 147. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 148. RUIDE Bio IVIG Product Offered
Table 149. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 150. RUIDE Bio Main Business
Table 151. RUIDE Bio Latest Developments
Table 152. BOYA Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 153. BOYA Bio IVIG Product Offered
Table 154. BOYA Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 155. BOYA Bio Main Business
Table 156. BOYA Bio Latest Developments
Table 157. RUIDE Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 158. RUIDE Bio IVIG Product Offered
Table 159. RUIDE Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 160. RUIDE Bio Main Business
Table 161. RUIDE Bio Latest Developments
Table 162. Xinxing Medicine Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 163. Xinxing Medicine IVIG Product Offered
Table 164. Xinxing Medicine IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 165. Xinxing Medicine Main Business
Table 166. Xinxing Medicine Latest Developments
Table 167. Weilun Bio Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 168. Weilun Bio IVIG Product Offered
Table 169. Weilun Bio IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 170. Weilun Bio Main Business
Table 171. Weilun Bio Latest Developments
Table 172. WIBP Basic Information, IVIG Manufacturing Base, Sales Area and Its Competitors
Table 173. WIBP IVIG Product Offered
Table 174. WIBP IVIG Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 175. WIBP Main Business
Table 176. WIBP Latest Developments
List of Figures
Figure 1. Picture of IVIG
Figure 2. IVIG Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global IVIG Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global IVIG Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. IVIG Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Injection IVIG
Figure 10. Product Picture of Lyophilized Powder IVIG
Figure 11. Global IVIG Sales Market Share by Type in 2021
Figure 12. Global IVIG Revenue Market Share by Type (2017-2022)
Figure 13. IVIG Consumed in Multiple Sclerosis(MS)
Figure 14. Global IVIG Market: Multiple Sclerosis(MS) (2017-2022) & (K Pcs)
Figure 15. IVIG Consumed in Myasthenia Gravis(MG)
Figure 16. Global IVIG Market: Myasthenia Gravis(MG) (2017-2022) & (K Pcs)
Figure 17. IVIG Consumed in Multifocal Motor Neuropathy(MMN)
Figure 18. Global IVIG Market: Multifocal Motor Neuropathy(MMN) (2017-2022) & (K Pcs)
Figure 19. IVIG Consumed in Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Figure 20. Global IVIG Market: Multifocal Acquired Sensory and Motor Neuropathy(MADSAM) (2017-2022) & (K Pcs)
Figure 21. IVIG Consumed in Dermatomyositis
Figure 22. Global IVIG Market: Dermatomyositis (2017-2022) & (K Pcs)
Figure 23. IVIG Consumed in Polymyositis
Figure 24. Global IVIG Market: Polymyositis (2017-2022) & (K Pcs)
Figure 25. Global IVIG Sales Market Share by Application (2017-2022)
Figure 26. Global IVIG Revenue Market Share by Application in 2021
Figure 27. IVIG Revenue Market by Company in 2021 ($ Million)
Figure 28. Global IVIG Revenue Market Share by Company in 2021
Figure 29. Global IVIG Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global IVIG Revenue Market Share by Geographic Region in 2021
Figure 31. Global IVIG Sales Market Share by Region (2017-2022)
Figure 32. Global IVIG Revenue Market Share by Country/Region in 2021
Figure 33. Americas IVIG Sales 2017-2022 (K Pcs)
Figure 34. Americas IVIG Revenue 2017-2022 ($ Millions)
Figure 35. APAC IVIG Sales 2017-2022 (K Pcs)
Figure 36. APAC IVIG Revenue 2017-2022 ($ Millions)
Figure 37. Europe IVIG Sales 2017-2022 (K Pcs)
Figure 38. Europe IVIG Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa IVIG Sales 2017-2022 (K Pcs)
Figure 40. Middle East & Africa IVIG Revenue 2017-2022 ($ Millions)
Figure 41. Americas IVIG Sales Market Share by Country in 2021
Figure 42. Americas IVIG Revenue Market Share by Country in 2021
Figure 43. United States IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC IVIG Sales Market Share by Region in 2021
Figure 48. APAC IVIG Revenue Market Share by Regions in 2021
Figure 49. China IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 53. India IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe IVIG Sales Market Share by Country in 2021
Figure 56. Europe IVIG Revenue Market Share by Country in 2021
Figure 57. Germany IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 58. France IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa IVIG Sales Market Share by Country in 2021
Figure 63. Middle East & Africa IVIG Revenue Market Share by Country in 2021
Figure 64. Egypt IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country IVIG Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of IVIG in 2021
Figure 70. Manufacturing Process Analysis of IVIG
Figure 71. Industry Chain Structure of IVIG
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...